Prokarium Limited
7Patents
7Active
7Granted
54Portfolio score
Filing activity: Jun 16, 2009 → Dec 6, 2022 · 2 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8703153B2 | Salmonella vectored vaccines against Chlamydia and methods of use | Emerging Cross-Sectional Technologies | 17 | Active |
| US11529378B2 | Cancer therapy | Emerging Cross-Sectional Technologies | 1 | Active |
| US10806778B2 | Modified strain of Salmonella enterica Typhi | Emerging Cross-Sectional Technologies | 0 | Active |
| US10016467B2 | Formulations of viable cells for oral delivery | Emerging Cross-Sectional Technologies | 0 | Active |
| US12121551B2 | Cancer therapy | Emerging Cross-Sectional Technologies | 0 | Active |
| US12171791B2 | Cancer therapy with live attenuated bacteria | Emerging Cross-Sectional Technologies | 0 | Active |
| US12214001B2 | Cancer therapy | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.